Serplulimab

Biological Fosun Pharma USA Inc.
Total Payments
$25,266
Transactions
20
Doctors
13
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2024 $25,266 20 13

Payments by Nature

Nature of Payment Amount Transactions Share
Honoraria $22,800 7 90.2%
Food and Beverage $2,466 13 9.8%

Top Doctors Receiving Payments for Serplulimab

Doctor Specialty Location Total Records
, M.D Medical Oncology Wynnewood, PA $3,820 2
, M.D Hematology & Oncology Sacramento, CA $3,820 2
, MD Medical Oncology New Haven, CT $3,820 2
, M.D., PH.D Student in an Organized Health Care Education/Training Program Iowa City, IA $3,220 2
, MD Hematology & Oncology Seattle, WA $3,220 2
, MD Medical Oncology New York, NY $3,220 2
, MD Internal Medicine Burlington, MA $3,220 2
, MD Hematology & Oncology Fort Lauderdale, FL $181.08 1
, MD Internal Medicine Philadelphia, PA $181.08 1
, MD, PHD Hematology & Oncology Columbus, OH $181.08 1
, M.D Hematology & Oncology Philadelphia, PA $181.08 1
, MD Internal Medicine Houston, TX $181.08 1
, MD Hematology & Oncology Omaha, NE $20.00 1

About Serplulimab

Serplulimab is a biological associated with $25,266 in payments to 13 healthcare providers, recorded across 20 transactions in the CMS Open Payments database. The primary manufacturer is Fosun Pharma USA Inc..

Payment data is available from 2024 to 2024. In 2024, $25,266 was paid across 20 transactions to 13 doctors.

The most common payment nature for Serplulimab is "Honoraria" ($22,800, 90.2% of total).